System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

INMB

$1.31-1.50%

INmune Bio Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

40Neutral

Live Analysis Active

Company Mission

INmune Bio Inc creates immunotherapies that help the body's immune system attack diseases such as cancer and neurological disorders. Doctors and patients use these treatments because they offer new ways to fight illnesses with fewer side effects. The company makes money by conducting clinical trials and aims to sell approved drugs to healthcare providers.

INM

Industry Context

This company operates in the biotechnology sector, focusing on developing treatments that enhance the immune system to fight diseases like cancer and Alzheimer's. It competes with other biotech firms by targeting specific pathways in the body's defense mechanisms. Revenue comes from funding clinical trials and future drug approvals, which can lead to significant market opportunities.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

82Matrix

Market Momentum

44.2— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.4x— Normal Volume

Today's Change

-1.50%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing INMB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:42 AM UTC

Develops immunotherapies for cancer and neurological diseases by boosting the body's natural defenses, generating revenue through clinical trials and potential drug sales.

No technical indicators available, but watch for price breaking above $1.50 as a potential signal of investor confidence in trial results.

Volume data is absent, but monitor if volume exceeds 1 million shares to confirm institutional interest in the company's progress.

Industry trends favor biotech innovation, with price holding above $1.50 support, signaling resilience in a volatile sector.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...